Table 5.
Comparison of comprehensive examinations with SPVAC test.
| SPVAC-P/SVS-F group #1 (eyes) |
SPVAC-F/SVS-P group #2 (eyes) |
SPVAC-F/SVS-F group #3 (eyes) |
P-value | |
|---|---|---|---|---|
| Normal | 58/158 (36.7%) | 24/28 (86.0%) | 10/76 (13.2%) | *#1 vs #2 <.001 *#1 vs #3 <.001 *#2 vs #3 <.001 |
| Hyperopia | 31 | 11 | 1 | |
| Astigmatism | 18 | 3 | 4 | |
| Myopia | 9 | 10 | 5 | |
| Treatment needed | 88/158 (56.7%) | 2/28 (7.0%) | 60/76 (78.9%) | |
| Hyperopia | 3 | 1 | 3 | |
| Astigmatism | 6 | 0 | 5 | |
| Myopia | 3 | 1 | 4 | |
| Ametropic amblyopia | 56 | 0 | 37 | †SPVAC pass group vs SPVAC no pass group (#1 vs #2 + #3)† .503 |
| Anisometropic amblyopia | 8 | 0 | 11 | |
| Esotropia/ esophoria | 8 | 0 | 0 | |
| Exotropia/ exophoria | 3 | 0 | 0 | |
| Oblique muscle dysfunctions | 1 | 0 | 0 | |
| Diagnosis is impossible | 12/158 (7.6%) | 2/28 (7.0%) | 6/76 (7.9%) |
F = fail, P = pass, SPVAC = single-picture optotype visual acuity chart, SVS = Spot™ Vision Screener.
*Fishers exact test with Bonferroni correction.
†
Fishers exact test.